From large trials and the GISSI Prevenzione study to field secondary prevention
Novo, S.; Mansueto, P.; Caruso, R.; Tantillo, R.; Evola, G.; Evola, S.; Strano, A.; Mansueto, S.
Cardiologia 44 Suppl. 1(Pt 2): 747-750
1999
ISSN/ISBN: 0393-1978 PMID: 12497816 Document Number: 511343
Document emailed within 1 workday
Related Documents
Marchioli, R. 1999: Results of GISSi Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSi Prevenzione Cardiologia 44 Suppl 1(Part 2): 745-746Piwowar-Manning, E.; Fiamma, A.; Laeyendecker, O.; Kulich, M.; Donnell, D.; Szekeres, G.; Robins-Morris, L.; Mullis, C.E.; Vallari, A.; Hackett, J.; Mastro, T.D.; Gray, G.; Richter, L.; Alexandre, M.W.; Chariyalertsak, S.; Chingono, A.; Sweat, M.; Coates, T.; Eshleman, S.H. 2011: HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043) Bmc Infectious Diseases 11: 251
Mafrici, A.; Mauri, F.; Maggioni, A.P.; Franzosi, M.G.; Santoro, L.; De Vita, C. 1995: Atenolol I.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. the GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico Giornale Italiano di Cardiologia 25(3): 353-364
Diener, H.C. 1997: Antiplatelet drugs in secondary prevention of stroke: lessons from recent trials Neurology 49(5 Suppl. 4): S75-S81
Karmisholt, K.; Gøtzsche, P.C. 2005: Physical activity for secondary prevention of disease. Systematic reviews of randomised clinical trials Danish Medical Bulletin 52(2): 90-94
Decorde, P. 1984: Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration Pharmatherapeutica 3(8): 515-525
Laeyendecker, O.; Piwowar-Manning, E.; Fiamma, A.; Kulich, M.; Donnell, D.; Bassuk, D.; Mullis, C.E.; Chin, C.; Swanson, P.; Hackett, J.; Clarke, W.; Marzinke, M.; Szekeres, G.; Gray, G.; Richter, L.; Alexandre, M.W.; Chariyalertsak, S.; Chingono, A.; Celentano, D.D.; Morin, S.F.; Sweat, M.; Coates, T.; Eshleman, S.H. 2013: Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043) Plos one 8(7): E68349
Fraser, I.S.; Zeun, S.; Parke, S.; Wilke, B.; Junge, W.; Serrani, M. 2013: Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials Reproductive Sciences 20(7): 745-754
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Louisirirotchanakul, S.; Kanoksinsombat, C.; Thongput, A.; Puthavathana, P.; Wasi, C. 2001: Anti-HIV-1 antibody testing using modified gelatin particle agglutination: a large field study Journal of the Medical Association of Thailand 84(12): 1708-1713
Bonetti, M.G.; Gregori, S.; Lamarche, V.; Radice, E.; Spiga, G.; Maggi, S.; Giorgini, P.; Giovagnoni, A.; De Nigris, E.; Amici, F. 1989: Radiological study of the thorax. Evaluation of efficacy-efficiency of a large-field image intensifier in mass screening La Radiologia Medica 78(3): 178-184
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Ferguson, H.M.; Ng'habi, K.R.; Walder, T.; Kadungula, D.; Moore, S.J.; Lyimo, I.; Russell, T.L.; Urassa, H.; Mshinda, H.; Killeen, G.F.; Knols, B.Gj. 2008: Establishment of a large semi-field system for experimental study of African malaria vector ecology and control in Tanzania Malaria Journal 7: 158
Taylor, P.R.; Li, B.; Dawsey, S.M.; Li, J.Y.; Yang, C.S.; Guo, W.; Blot, W.J. 1994: Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group Cancer Research 54(7 Suppl): 2029s-2031s
Dhalla, S.; Poole, G. 2014: Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention Human Vaccines and Immunotherapeutics 10(7): 1974-1984
Scheen, A.J. 2001: Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study Revue medicale de Liege 56(11): 792-795
Algra, A. 1994: SPIRIT: new life spirit for anticoagulant treatment in the secondary prevention of brain infarcts? A new study. Stroke Prevention in Reversible Ischaemia Trial Nederlands Tijdschrift Voor Geneeskunde 138(20): 1037-1039
Schiefer, U.; Gisolf, A.C.; Kirsch, J.; Selbmann, H.K.; Zrenner, E. 1996: Noise field screening. Results of a television field study for detection of visual field defects Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 93(5): 604-616
Tognoni, G. 1995: Lisinopril: myocardial infarction, the first 24 hours, in patients with stable hemodynamic status. the GISSI-3 study; results at 6 weeks Archives des Maladies du Coeur et des Vaisseaux 88(Special Issue 3): 25-34
Arko, D.; Takac, I. 2001: A prospective study of the correlation between Chlamydia trachomatis infection and secondary bleeding following large loop excision of the transformation zone (LLETZ) Wiener Klinische Wochenschrift 113(Suppl 3): 11-13